| Ssm Health Medical Group | |
|
1120 Shackelford Rd Florissant MO 63031 | |
| (314) 921-4420 | |
| (314) 921-6086 |
| Full Name | Ssm Health Medical Group |
|---|---|
| Speciality | Durable Medical Equipment & Medical Supplies |
| Location | 1120 Shackelford Rd, Florissant, Missouri |
| Authorized Official Name and Position | Karen Rewerts (VP FINANCIAL OPERATIONS) |
| Authorized Official Contact | 3149892034 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ssm Health Medical Group Po Box 955534 Saint Louis MO 63195-5534 Ph: () - | Ssm Health Medical Group 1120 Shackelford Rd Florissant MO 63031 Ph: (314) 921-4420 |
| NPI Number | 1194736116 |
|---|---|
| Provider Enumeration Date | 08/11/2006 |
| Last Update Date | 08/18/2020 |
| Medicare PECOS PAC ID | 6608776299 |
|---|---|
| Medicare Enrollment ID | O20180922000132 |
News Archive
dbMotion, an innovative provider of connected healthcare solutions, has been selected to implement its interoperability platform across Fraser Health, a 12-hospital integrated delivery network (IDN) serving 1.7 million people in the Greater Vancouver area of British Columbia, Canada.
Thanks to a $50,000 grant from the California Bipolar Foundation (CBF) to post-doctoral research fellow Dr. Illyas Singec at the Burnham Institute for Medical Research (BIMR), a research team headed by Dr. Evan Snyder (along with co-investigators Drs. Dieter Wolfe and Lawrence Brill), was able to accumulate sufficient preliminary data to win an extremely competitive Grand Opportunities (GO) grant from the National Institute of Mental Health to explore the molecular basis of Bipolar Disorder (BPD).
Researchers at Erasmus MC University Medical Centre in The Netherlands found that cyclosporine treatment is a significant risk factor for the development of de novo cancer in liver transplant patients. Full details appear in the July issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
Researchers in the UK have provided evidence that Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine induces effective immune responses in patients with myeloproliferative neoplasms.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194736116 | NPI | - | NPPES |
News Archive
dbMotion, an innovative provider of connected healthcare solutions, has been selected to implement its interoperability platform across Fraser Health, a 12-hospital integrated delivery network (IDN) serving 1.7 million people in the Greater Vancouver area of British Columbia, Canada.
Thanks to a $50,000 grant from the California Bipolar Foundation (CBF) to post-doctoral research fellow Dr. Illyas Singec at the Burnham Institute for Medical Research (BIMR), a research team headed by Dr. Evan Snyder (along with co-investigators Drs. Dieter Wolfe and Lawrence Brill), was able to accumulate sufficient preliminary data to win an extremely competitive Grand Opportunities (GO) grant from the National Institute of Mental Health to explore the molecular basis of Bipolar Disorder (BPD).
Researchers at Erasmus MC University Medical Centre in The Netherlands found that cyclosporine treatment is a significant risk factor for the development of de novo cancer in liver transplant patients. Full details appear in the July issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
Researchers in the UK have provided evidence that Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine induces effective immune responses in patients with myeloproliferative neoplasms.
› Verified 7 days ago
Northwest Physicians Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1225 Graham Rd, Suite 220, Florissant, MO 63031 Phone: 314-838-6700 Fax: 314-838-6020 | |
Kim Lee Mcdonald, M.d., P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4585 Washington St, Suite C4, Florissant, MO 63033 Phone: 314-838-8839 Fax: 314-838-4291 | |
Bjc Medical Group North County Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1150 Graham Rd, Suite 101, Florissant, MO 63031 Phone: 314-831-6737 Fax: 314-831-9269 | |
Chambers Medical Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3533 Dunn Rd, Suite 204, Florissant, MO 63033 Phone: 314-831-2600 Fax: 314-831-5393 | |
Chandra S. Kaup,m.d.,p.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1224 Graham Rd, Suite 2006, Florissant, MO 63031 Phone: 314-830-5233 Fax: 314-830-5225 | |
Total Access Urgent Care, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1090 N Highway 67 St, Florissant, MO 63031 Phone: 314-961-2255 Fax: 314-270-3694 |